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Type 2 innate lymphoid cells (ILC2s), an innate
source of the type 2 cytokines interleukin (IL)-5 and
-13, participate in the maintenance of tissue homeo-
stasis. Although type 2 immunity is critically impor-
tant for mediating metabolic adaptations to environ-
mental cold, the functions of ILC2s in beige or brown
fat development are poorly defined. We report here
that activation of ILC2s by IL-33 is sufficient to pro-
mote the growth of functional beige fat in thermoneu-
tral mice. Mechanistically, ILC2 activation results in
the proliferation of bipotential adipocyte precursors
(APs) and their subsequent commitment to the beige
fat lineage. Loss- and gain-of-function studies reveal
that ILC2- and eosinophil-derived type 2 cytokines
stimulate signaling via the IL-4Ra in PDGFRa+ APs
to promote beige fat biogenesis. Together, our re-
sults highlight a critical role for ILC2s and type 2 cy-
tokines in the regulation of adipocyte precursor
numbers and fate, and as a consequence, adipose
tissue homeostasis.
INTRODUCTION
White adipose tissue (WAT) is a highly dynamic organ that re-
sponds to nutrient and environmental stress (Berry et al., 2014;
Rosen and Spiegelman, 2006; Rosen and Spiegelman, 2014;
Zeve et al., 2009). When mammals are in positive energy bal-
ance, WAT expands by hyperplasia and hypertrophy to store
excess nutrients. In contrast, prolonged cold stress induces
catabolic programs in WAT depots, in particular in the subcu-
taneous WAT (scWAT) of mice, to support thermogenesis
(Harms and Seale, 2013;Wu et al., 2013). In this case, adrenergic
stimulation of scWAT promotes tissue ‘‘browning’’ via induction
of beige adipocytes that express the uncoupling protein 1
(UCP1). This de novo recruitment of beige adipocytes alleviates
cold stress to restore thermal homeostasis (Nedergaard and
Cannon, 2014). Despite progress in this field, the physiologic sig-74 Cell 160, 74–87, January 15, 2015 ª2015 Elsevier Inc.nals that regulate adipocyte precursor proliferation and their
subsequent commitment to the beige adipocyte lineage remain
poorly understood.
Fate mapping studies have led to the identification of progen-
itor or precursor cell populations that give rise to brown and
beige adipocytes in adult mice. These studies have revealed
that interscapular brown adipocytes arise from a mesodermal
progenitor that transiently expresses the myogenic transcription
factorsMyf5 and Pax7 (Lepper and Fan, 2010; Seale et al., 2008).
In contrast, beige adipocytes, which are found in WAT depots of
mice, primarily arise from Myf5 PDGFRa+ precursor cells (San-
chez-Gurmaches et al., 2012; Seale et al., 2008). Fate mapping
studies by the Granneman laboratory have elegantly demon-
strated that pharmacologic activation of the b3-adrenergic re-
ceptor stimulates the proliferation of PDGFRa+ precursor cells,
which subsequently differentiate into beige adipocytes (Lee
et al., 2012). Interestingly, these PDGFRa+ precursor cells can
also give rise to white adipocytes in the setting of dietary obesity
(Berry and Rodeheffer, 2013; Hudak et al., 2014; Lee et al., 2012;
Wang et al., 2014), suggesting that environmental signals likely
dictate the commitment of PDGFRa+ precursor cells to the beige
or white adipocyte lineage.
Exposure of adult animals to environmental cold stimulates the
growth of thermogenic beige fat via activation of adrenergic
signaling pathways (Harms and Seale, 2013; Wu et al., 2013).
In contrast to interscapular BAT, we recently reported that the
scWAT relies on a hematopoietic circuit consisting of eosinophils
and alternatively activated macrophages for the maintenance of
its adrenergic tone. In response to environmental cold, we found
that eosinophil-derived interleukin (IL)-4 induces the expression
tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthe-
sis of catecholamines, in alternatively activated macrophages
(Nguyen et al., 2011; Qiu et al., 2014). Accordingly, genetic dele-
tion of Il4ra or Th in myeloid cells significantly impaired the devel-
opment of thermogenic beige fat in mice (Qiu et al., 2014). The
observation that other browning factors, such as meteorin-like
(METRNL) also utilize this pathway for their thermic effects
(Rao et al., 2014), suggests that type 2 innate immunity might
be integrally linkedwith the development of beige adipose tissue.
ILC2s, which are present in lymphoid and nonlymphoid tissues
(Moro et al., 2010; Neill et al., 2010; Price et al., 2010),
orchestrate type 2 innate and adaptive immune responses in the
setting of tissue damage, helminth infection, and allergen expo-
sure (Koyasu and Moro, 2013; McKenzie et al., 2014; Walker
et al., 2013). In these scenarios, the release of epithelial cell-
derived cytokines IL-33, IL-25, and thymic stromal lymphopoie-
tin (TSLP) results in the activation of ILC2s, which then secrete
IL-5 and IL-13 to initiate type 2 immune responses (Cayrol and
Girard, 2014; Licona-Limo´n et al., 2013). For instance, in the
absence of ILC2s or IL-4/13, the allergen chitin is unable to pro-
mote recruitment of eosinophils or alternatively activatedmacro-
phages in the lungs (Van Dyken et al., 2014). In addition to their
functions in immunity at mucosal sites, ILC2s have been identi-
fied in epididymal WAT (eWAT) of mice, where they sustain eo-
sinophils and alternatively activated macrophages to promote
glucose homeostasis (Molofsky et al., 2013). Since ILC2-derived
IL-5 and IL-13 are critical for initiating type 2 immune responses,
we asked whether these cells might also orchestrate the devel-
opment of beige fat in mice.
Here, we report that administration of IL-33 results in accumu-
lation and activation of ILC2s in the scWAT of mice to stimulate
biogenesis of functional beige fat. Surprisingly, in an IL-4/13-
dependent manner, IL-33 stimulates the proliferation of
PDGFRa+ adipocyte precursor cells, which then commit to the
beige adipocyte lineage. The dependence of APs on IL-4/13
signaling for their expansion and commitment to beige adipo-
cytes is not restricted to their pharmacological activation by IL-
33 but is also observed during normal physiologic development
of this tissue.
RESULTS
IL-33 Promotes Growth of Functional Beige Fat in
Thermoneutral Mice
To investigate the functions of ILC2s in beige fat development,
we intraperitoneally administered IL-33 to thermoneutral mice
daily for 8 days to activate tissue resident ILC2s. In a dose-
dependent manner, administration of IL-33 led to a robust
increase in the expression of UCP1 protein in the scWAT of ther-
moneutral C57BL/6J mice (Figures 1A and 1B), suggesting that
IL-33 stimulates the growth of beige fat. This browning of scWAT
by IL-33 was comparable in magnitude to that induced by the
type 2 cytokines IL-4 or IL-13 (Figure 1C), which previously
have been implicated in the development of beige fat (Qiu
et al., 2014; Rao et al., 2014). Histologic analysis confirmed the
presence of multilocular beige adipocytes in the scWAT of
mice treated with IL-33 (Figures 1D and 1E). In contrast to
browning of scWAT, administration of IL-33, IL-13, or IL-4 did
not alter the expression of UCP1 protein in the interscapular
brown adipose tissue (BAT) of thermoneutral mice (Figure 1C).
Together with our previous studies, these results demonstrate
a selective role for type 2 cytokines in stimulating beige fat
development.
Next, we asked whether IL-33-induced browning of scWAT
contributes to whole-body energy expenditure. To test this
postulate, we quantified energy expenditure in vehicle- and IL-
33-treated mice at different environmental temperatures.
Although energy expenditure was similar in vehicle- and IL-33-
treated mice at thermoneutrality (30C), animals treated withIL-33 had higher energy expenditure (13%–17%) at the cooler
housing temperatures (Figures 1F and 1G), which likely reflects
activation of recruited beige fat. Moreover, these results are
consistent with the previous reports demonstrating that beige
fat thermogenesis is stimulated by cold exposure in both mice
and humans (Qiu et al., 2014; van der Lans et al., 2013; Yoneshiro
et al., 2013).
Based on these results, we next investigated whether IL-33 in-
creases energy expenditure in a UCP1-dependent manner. For
these experiments, thermoneutral C57BL/6J and congenic
Ucp1/ mice were administered IL-33 for 8 days (Figure 1A),
and oxygen consumption was quantified after injection of
norepinephrine (NE). Administration of NE, which activates all
adrenoreceptors to maximally stimulate thermogenesis (Golo-
zoubova et al., 2006), transiently increased oxygen consumption
in thermoneutral C57BL/6J mice (Figure 1H). This NE-stimulated
increase in metabolic rate was markedly enhanced in C57BL/6J
mice that were administered IL-33 (Figure 1H). Importantly, IL-
33-induced increase in oxygen consumption was completely ab-
sent in Ucp1/ mice (Figure 1I), indicating that IL-33-induced
recruitment of beige fat is critical for increasing the total thermo-
genic capacity of these mice.
IL-33 Stimulates Proliferation and Commitment of
Adipocyte Precursors to the Beige Fat Lineage
To uncover the mechanisms by which IL-33 promotes brown-
ing of scWAT, we characterized the immune and precursor
populations present in the scWAT of mice. For these studies,
we used heterozygous Red5 (Il5Red5/+, R5) mice, which express
tandem dimer red fluorescent protein (tdTomato) from the
translation initiation site of the endogenous Il5 locus (Nuss-
baum et al., 2013), to monitor the fate and activation of
ILC2s. ILC2s residing in the scWAT of mice were identified
as being Lin (CD11bCD4CD5Cd11cNK1.1)Thy1.2+T1/
ST2+KLRG1+ cells (Figure S1A available online). In mice admin-
istered IL-33, ILC2s but not eosinophils, basophils or mast cells
were the dominant source of IL-5 (Figures S1B and S1C).
Furthermore, daily treatment with IL-33 for 8 days increased
the numbers (22-fold) and activation (5.4-fold) of ILC2s in
the scWAT (Figures 2A and 2B). This increase in ILC2 activation
was accompanied by tissue eosinophilia and proliferation of
PDGFRa+ APs (14-fold, as assessed by intracellular staining
for cell proliferation antigen Ki67) (Figures 2C–2E, S2A, and
S2B). Since PDGFRa+ APs are bipotential cells capable of
differentiating into white or beige adipocytes (Lee et al.,
2012), we hypothesized that IL-33 might stimulate beige fat
biogenesis by enhancing the commitment of APs to the beige
fat lineage. To test this idea, we used flow cytometry to monitor
the expression of beige adipocyte markers (TMEM26 and
CD137) on PDGFRa+ APs (Wang et al., 2014; Wu et al.,
2012). We found that treatment with IL-33 increased the
expression of TMEM26 and CD137 on the cell surface of
PDGFRa+ APs (Figures 2F, 2G, S2C, and S2D), suggesting
that IL-33 enhances the growth of beige fat by altering the pro-
liferative and differentiation potential of scWAT APs.
We next investigated the signaling pathways by which IL-33
stimulates the expansion of APs. We hypothesized that IL-33 it-
self or factors secreted by IL-33 activated ILC2s, such as IL-5Cell 160, 74–87, January 15, 2015 ª2015 Elsevier Inc. 75
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Figure 1. IL-33 Promotes Growth of Functional Beige Fat in Thermoneutral Mice
(A) Schematic for cytokine administration and metabolic analysis in thermoneutral mice.
(B) Immunoblotting for UCP1 in the scWAT of thermoneutral C57BL/6J administered various doses of IL-33 over 8 days (n = 2–3 per treatment dose).
(C) Immunoblotting for UCP1 in the scWAT and BAT of thermoneutral mice administered IL-33, IL-13, or IL-4 for 8 days (n = 3 per cytokine treatment).
(D and E) Representative sections of scWAT from thermoneutral C57BL/6J mice administered Vehicle (Veh) or IL-33 were stained with hematoxylin and eosin. (D)
1003 magnification, (E) 4003 magnification.
(legend continued on next page)
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or IL-13 (Koyasu and Moro, 2013; McKenzie et al., 2014;
Walker et al., 2013), directly stimulate the proliferation of
PDGFRa+ APs. Flow cytometric analysis revealed that
PDGFRa+ APs did not express the receptors required for
signaling by IL-33 (IL1RL1) or IL-5 (IL-5Ra), but they did ex-
press IL-4Ra (Figures 2H–2J and S2E), which is required for
both IL-13 and IL-4 signaling (Kelly-Welch et al., 2003). These
observations led us to hypothesize that secretion of IL-13 by
activated ILC2s or IL-4 by recruited eosinophils might support
the proliferative burst of APs. We first tested the requirement
for IL-5 in IL-33 stimulated AP proliferation. Albeit to a slightly
lower extent than in WT mice, stimulation with IL-33 enhanced
AP proliferation in R5R5 (Il5Red5/Red5) homozygous mice (Fig-
ure S2F), which lack the eosinophil growth factor IL-5 but can
secrete IL-13 upon activation (Figures S1D and S2G). Since eo-
sinophils are an important source of IL-4 in WAT (Qiu et al.,
2014; Wu et al., 2011), we next tested their requirement in IL-
33-mediated AP proliferation. Figure S2H shows that IL-33
was equally efficacious in stimulating expansion of scWAT
APs in eosinophil-deficient DdblGATA mice (Yu et al., 2002),
suggesting potential redundancy between eosinophil-derived
IL-4 and ILC2-dervied IL-13 in mediating this response. To
test this hypothesis, we asked whether IL-33 could stimulate
proliferation of APs in Il4/13/ and Il4ra/ mice. Indeed,
administration of IL-33 failed to increase proliferation of APs
in the scWAT of Il4/13/ and Il4ra/ mice (Figures 2K and
2L). A similar requirement for type 2 cytokine signaling was
observed in IL-33-mediated browning of scWAT, as monitored
by the expression of UCP1 protein in the scWAT of thermoneu-
tral WT and Il4ra/ mice administered IL-33 (Figure 2M).
Together, these findings establish a hierarchy between ILC2s,
eosinophils, and signaling via the IL-4Ra in the regulation of
AP biology.
To test whether the stimulatory effects of IL-33 on AP prolifer-
ation and commitment require ILC2s, we administered IL-33 to
Rag2/ and Rag2Il2rg/ mice, the latter known to lack ILC2s
(Price et al., 2010). While IL-33 increased AP proliferation in
Rag2/mice, it failed to do so in Rag2Il2rg/mice (Figure 2N),
indicating an absolute requirement for ILC2s in IL-33-mediated
expansion of scWAT APs. Similarly, the induction of beige
adipocyte markers, TMEM26 and CD137, by IL-33 was only
observed in Rag2/ mice (Figures 2O, 2P, S2I, and S2J), sug-
gesting that ILC2s are the likely target for IL-33-induced brown-
ing of scWAT.
Physiologic Expansion of Adipocyte Precursors Is
Controlled by Type 2 Cytokine Signaling
Since pharmacologic activation of ILC2s promoted proliferation
of adipogenic precursors in an IL-4/13-dependent manner, we
next asked whether these signals might control the physiologic
expansion of APs during the postnatal period. We first quanti-
fied the proliferative status of PDGFRa+SCA1+CD45CD31
APs in the scWAT of C57BL/6J mice at various ages (Figures(F) Cold-induced changes in oxygen consumption in thermoneutral C57BL/6J m
(G) Oxygen consumption rate at various temperatures of C57BL/6J mice treated
(H and I) Norepinephrine stimulated changes in oxygen consumption (VO2) in cons
vehicle (Veh) or IL-33 for 8 days (n = 5 per genotype and treatment). Data are repS3A and S3B). We found that proliferation of scWAT APs, as
assessed by intracellular staining for the cell proliferation anti-
gen Ki67, was age dependent (Figure 3A). Approximately
5.8% of scWAT APs stained positive for Ki67 in 4-week-old
mice, which declined by 85% and 95%, respectively, in the
scWAT of 8- and 12-week-old mice (Figure 3A). BrdU incorpo-
ration experiments provided independent verification for this
age-associated decline in DNA synthesis and AP proliferation
(Figure 3B).
We next asked whether type 2 immunity regulates this post-
natal expansion of APs in the WAT. In support of our hypothe-
sis, we observed an age-associated decline in type 2 cytokine
signaling in APs, as assessed by the phosphorylation status of
signal transducer and activator of transcription 6 (STAT6),
which mediates the biological effects of type 2 cytokines IL-4
and IL-13 (Figure 3C) (Kelly-Welch et al., 2003). Using 4get
mice, which express green fluorescent protein (GFP) from the
Il4 locus (Mohrs et al., 2001), we next asked whether the num-
ber of cells competent for IL-4 production in scWAT changes
with age. Congruent with the decrease in levels of pSTAT6 (Fig-
ure 3C), the scWAT of 9-week-old mice had 70% fewer GFP+
cells. This decrease in GFP+ cells primarily reflected a decline
in the numbers of resident eosinophils (Figure S3C), which
have previously been implicated in secretion of IL-4 in scWAT
and eWAT (Qiu et al., 2014; Wu et al., 2011). Furthermore,
this reduction in numbers of GFP+ eosinophils was associated
with a 70% decrease in proliferation (Ki67 positivity) and a
50% reduction in numbers of APs present in the scWAT (Fig-
ures S3D and S3E). A similar age-associated decline in prolifer-
ation of APs was observed in the scWAT and eWAT of BALB/cJ
mice (Figures S3F and S3G), suggesting that this is not a strain-
specific effect. Finally, this age-associated decrease in AP pro-
liferation was not a consequence of changes in expression of
PDGFRa or IL-4Ra on the cell surface of APs (Figures S3H
and S3I).
Based on these results, we next asked whether loss of type 2
cells or signals affects AP proliferation and numbers in the
scWAT. For these studies, we focused on 5-week-old mice
because we observed robust proliferation of APs at this age in
both C57BL/6J and BALB/cJ mice. Consistent with our hypoth-
esis, DdblGATA mice, which lack eosinophils, had 30% fewer
APs in their scWAT with 70% lower proliferative fraction (Fig-
ures 3E and 3F). Il4/13/ mice, which lack the type 2 cytokines
IL-4 and IL-13, also demonstrated decreases in scWAT AP pro-
liferation (56%) and numbers (70%) (Figures 3G and 3H).
Similarly, deletion of the IL-4/13 signaling subunit Il4ra
decreased the percentage of Ki67+ APs by 48% and their
numbers by 52% in scWAT (Figures 3I and 3J). In aggregate,
these data suggest that signaling via the IL-4Ra accounts for
50% of the proliferative capacity of APs in the scWAT of
mice, prompting us to investigate the mechanisms by which
type 2 immunity instructs the postnatal development and func-
tions of this adipose depot.ice administered Vehicle (Veh) or IL-33 over 8 days (n = 4–5 per treatment).
with Veh or IL-33 (n = 4–5 per treatment).
cious, thermoneutral C57BL/6J (H) andUcp1/mice that were pretreated with
resented as mean ± SEM.
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Figure 2. IL-33 Stimulates Proliferation and Commitment of Adipocyte Precursors to the Beige Fat Lineage
(A and B) Quantification of ILC2 numbers (A) and activation status (B) in the scWAT of thermoneutral, heterozygous Red5 (Il5Red5/+) mice that were administered
vehicle (Veh) or IL-33 for 8 days. Expression of IL-5 (td Tomato) from the Red5 allele was used as a marker of ILC2 activation (n = 9–10 per treatment).
(legend continued on next page)
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Figure 3. Type 2 Cytokine Signaling Controls Physiologic Expansion of Adipocyte Precursors
(A) Age-dependent proliferation of adipocyte precursors (APs) in the scWAT of C57BL/6J mice as assessed by intracellular staining for Ki67 (n = 4–5 per age).
(B) Age-dependent incorporation of BrdU by scWAT APs in C57BL/6J mice (n = 4–5 per age).
(C) Quantification of pSTAT6 levels in scWAT APs of C57BL/6J mice at different ages (n = 10–11 per age).
(D) Quantification of IL-4-producing cells in the scWAT of 4get mice at different ages. GFP expressionmarks cells competent for production of IL-4 (n = 5 per age).
(E–J) Quantification of Ki67+ (E, G, and I) and total APs (F, H, and J) in scWAT of 5-week-oldDdblGATA (E, F), Il4/13/ (G and H), and Il4ra/ (I and J) mice (n = 5–
10 per genotype). Data are represented as mean ± SEM. See also Figure S3.IL-4Ra Signaling in PDGFRa+ Cells Promotes Expansion
of Adipocyte Precursors
Previous studies by the Granneman laboratory have demon-
strated that pharmacologic activation of the b3-adrenergic re-
ceptor stimulates the proliferation and differentiation of APs
into beige adipocytes (Lee et al., 2012). Since we recently(C) Quantification of eosinophils in the scWAT of thermoneutral heterozygous Re
treatment).
(D) Quantification of adipocyte precursor (AP) proliferation in the scWAT of therm
intracellular staining for Ki67 (D) and AP cell number per fat pad (n = 8–10 per tre
(F and G) Expression of beige adipocyte markers TMEM26 and CD137 on the sc
(n = 8–10 per treatment). Representative histograms for TMEM26 (F) and CD137
(H–J) Expression of IL1RLI (H), IL-5Ra (I), and IL-4Ra (J) on scWAT APs of mic
represents Il1rl1/ APs. For IL-5Ra (I), the dashed line histogram represents isoty
represents eosinophils stained for IL-5Ra. For IL-4Ra (J), the solid line histogram re
(K and L) Quantification of IL-33 induced AP proliferation in the scWAT of Il4/13
(M) Immunoblotting for UCP1 in the scWAT and BAT of thermoneutral WT and Il4
(N–P) Quantification of AP proliferation (N), TMEM26 (O) and CD137 (P) expression
and treatment).
Data are represented as mean ± SEM. See also Figure S1 and S2.demonstrated that type 2 activation of macrophages via IL-
4Ra stimulates release of norepinephrine in the scWAT and
eWAT of mice (Nguyen et al., 2011; Qiu et al., 2014), we next
asked whether myeloid cell IL-4Ra signaling might regulate the
postnatal expansion and commitment of APs to the beige adipo-
cyte lineage. To our surprise, we found that deletion of Il4ra ind5 (Il5Red5/+) mice that were administered Veh or IL-33 for 8 days (n = 8–10 per
oneutral Il5Red5/+ mice administered Veh or IL-33 for 8 days, as assessed by
atment).
WAT APs of thermoneutral Il5Red5/+ mice administered Veh or IL-33 for 8 days
(G) are shown; clear histogram-Veh, shaded histogram-IL-33.
e. For IL1RL1 (H), the clear histogram represents WT APs, while the shaded
pe, the solid line represents APs stained for IL-5Ra, and the shaded histogram
presents isotype and the shaded histogram represents APs stained for IL-4Ra.
/ (K) and Il4ra/ (L) mice (n = 4–8 per genotype and treatment).
ra/mice administered IL-33 for 8 days (n = 2–3 per genotype and treatment).
inRag2/ andRag2/Il2rgc/mice treatedwith IL-33 (n = 6–8 per genotype
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Figure 4. IL-4Ra Signaling in PDGFRa+ Cells Promotes Expansion of Adipocyte Precursors
(A) Quantification of scWAT adipocyte precursor (AP) proliferation in 5-week-old Il4raf/f and Il4raf/f/Lyz2Cre mice (n = 8–10 per genotype).
(B) Analysis of IL-4-induced phosphorylation of STAT6 (pSTAT6) in scWAT APs of Il4raf/f and Il4raf/f/PdgfraCre mice (n = 3–4 per genotype).
(C and D) Quantification of scWAT AP proliferation by Ki67 staining (C) and total number (D) in 5-week-old Il4raf/f and Il4raf/f/PdgfraCre mice (n = 7–12). (E)
Quantification of scWAT AP proliferation by Ki67 staining in 8- to 10-week-old C57BL/6J mice at 24 and 48 hr after injection with vehicle or IL-4 (n = 5 per time
point).
(F and H) BrdU incorporation by the scWAT APs of wild-type and Il4ra/mice (F) or Il4raf/f and Il4raf/f/PdgfraCremice (H) 48 hr after administration of IL-4 (n = 6–8
per genotype and treatment).
(G) Quantification of scWAT AP proliferation by Ki67 staining 48 hr after administration of vehicle or IL-13 (n = 6–8 per genotype and treatment).
(I) Quantification of scWAT AP number in Il4raf/f and Il4raf/f/PdgfraCre mice 48 hr after administration of vehicle or IL-4 (n = 7 per genotype).
(J) APs purified fromwild-type and Il4ra/mice were stimulated with IL-4, and cellular proliferation was quantified by intracellular staining for Ki67 48 hr later (n =
4 per genotype and treatment).
(K) Quantification of scWAT AP proliferation in Il4raf/f and Il4raf/f/PdgfraCremice 48 hr after administration of vehicle or IL-33 (n = 8–10 per genotype and treatment).
Data are represented as mean ± SEM.
See also Figure S4.myeloid cells, as in Il4raf/fLyz2Cremice, did not significantly affect
the rate of AP proliferation or expression of beige adipocyte
markers in the scWAT (Figures 4A, S4A, and S4B), leading us80 Cell 160, 74–87, January 15, 2015 ª2015 Elsevier Inc.to hypothesize that IL-4/13 might directly stimulate AP prolifera-
tion. To address this possibility, we generatedmice in which Il4ra
was selectively deleted in PDGFRa+ cells (Il4raf/fPdgfraCre
mice). Consistent with the loss of IL-4Ra expression in APs (Fig-
ure S4C), IL-4 stimulated increase in pSTAT6 was reduced by
80% in scWAT APs, but not in the CD11b+ myeloid cells, of Il4-
raf/fPdgfraCre mice (Figures 4B, S4D, and S4E). Consequently,
both the proliferative capacity of APs and their numbers were
reduced by 54% and 43%, respectively, in 5-week-old Il4-
raf/fPdgfraCre mice (Figures 4C and 4D). These results indicate
that the type 2 cytokines IL-4 and IL-13 play a critical role in con-
trolling adipocyte precursor pool size by directly activating
IL-4Ra signaling in PDGFRa+ APs.
To investigate whether pharmacological activation of IL-4Ra
signaling is sufficient to stimulate the proliferation of APs in
scWAT, we injected 8- to 10-week-old mice with IL-4 as a
complex with anti-IL4 antibody, which prolongs its biological
half-life (Finkelman et al., 1993). As noted above, the rate of
AP proliferation declines with age (Figures 3A and 3B); how-
ever, this was restored by the administration of IL-4 to WT
mice. For instance, treatment of 8- to 10-week-old mice with
IL-4 complex increased the percentage of Ki67+ APs by
5.5–7.5-fold within 24–48 hr (Figure 4E). This stimulation of
AP proliferation by IL-4 or IL-13 was an on-target effect of
these cytokines because it required IL-4Ra (Figures 4F and
4G). Furthermore, administration of IL-4 complex failed to
stimulate DNA synthesis or cellular proliferation in APs of
Il4raf/fPdgfraCre mice (Figures 4H and S4F), confirming that IL-
4 stimulates the growth of APs in a cell autonomous manner.
After 48 hr, the number of APs present in scWAT also increased
by 2.5-fold, demonstrating that stimulation with IL-4 is suffi-
cient to expand the pool of PDGFRa+ APs that reside within
scWAT (Figures 4I and S4G). Again, this increase in AP number
was dependent on cell autonomous signaling via the IL-4Ra in
PDGFRa+ cells (Figure 4I). Purification of APs from wild-type,
Il4ra/, and Stat6/ mice provided independent verification
for the direct proliferative effects of IL-4 on APs (Figures S4H,
S4I, and 4J). Finally, we tested whether IL-33-induced prolifer-
ation of APs requires cell autonomous signaling via the IL-4Ra.
Indeed, while IL-33 robustly induced AP proliferation (19-fold)
in the scWAT of Il4raf/f mice, it failed to do so in Il4raf/fPdgfraCre
mice (Figure 4K). In a similar manner, the induction of IL-4Ra
and beige adipocyte markers (TMEM26 and CD137) by IL-33
was absent in Il4raf/fPdgfraCre mice (Figures S4J–S4L). In
aggregate, these results demonstrate that the IL-33/ILC2/IL-
4Ra signaling pathway acts directly on scWAT APs to expand
the pool of beige adipogenic precursors.
IL-4 and IL-13 Direct Commitment of PDGFRa+
Adipocyte Precursors to Beige Adipogenic Precursors
PDGFRa+ APspresent in scWAT are bipotential cells that can give
rise to white or beige adipocytes (Berry et al., 2014; Lee et al.,
2012), prompting us to askwhether signaling via the IL-4Ramight
direct the commitment of APs to either lineage. Using purified
wild-type APs from the scWAT, we first investigated the effects
of IL-4 on their adipogenic conversion into white adipocytes. Fig-
ures S5A–S5C show that the addition of IL-4 during the initial
differentiation period inhibited the conversion of APs into white
adipocytes. Since differentiated adipocytes did not express IL-
4Ra at any appreciable level (Figure S5C), we hypothesized that
the biologic actions of type 2 cytokines might be restricted to adi-pogenic precursors. We thus asked whether, in the absence of
adipogenic stimuli, treatment with IL-4 altered the fate of purified
APs. Indeed, in a time-dependent manner, treatment of purified
APswith IL-4 induced the expression of a number of beige adipo-
cyte makers, including Klhl13, Ear2, Tmem26, and Tnfrsf9 (Fig-
ure 5A). Consistent with the distinct developmental lineages of
beige and brown adipocytes (Harms and Seale, 2013), exposure
to IL-4 did not alter the expression of brown fatmarkers in APspu-
rified from scWAT (Figure S5D). This commitment of APs to the
beige fat lineage was an on-target effect of IL-4 because it was
absent in APs isolated from Il4ra/ mice (Figure 5B).
We next askedwhether administration of IL-4 to wild-typemice
was sufficient to promote the expression of beige lineagemarkers
in APs. Cell surface expression of IL-4Ra, a known target of IL-4/
STAT6 signaling (Goenka and Kaplan, 2011), and the beige pre-
cursor markers CD137 (encoded by Tnfrsf9) and TMEM26 were
all induced in the scWAT APs upon treatment with IL-4 (Figures
5C–5H). The induction of these beige markers required intact
IL-4Ra signaling in PDGFRa+ cells because treatment with IL-4
failed to induce expression of CD137 and TMEM26 in scWAT
APs of Il4raf/fPdgfraCre mice (Figures 5I and 5J). Furthermore,
treatment of WT mice with IL-4 was also sufficient to increase
expression of beige cell markers in eWAT (Figures S6A–S6F), a
tissue that is normally refractory to cold-induced browning.
Consistent with these gain-of-function studies, loss of type 2
cytokine signaling, as in DdblGATA, Il4/13/, and Il4raf/fPdgfra-
Cre mice, decreased expression of beige precursor cell markers
in scWAT APs (Figures S6G–S6J and Figures 5K and 5L).
To investigate whether the induction of beige precursor
cell markers correlates with enhanced capacity for beige adipo-
genesis, we pretreated purified APs with IL-4 and then subjected
them to beige adipogenic stimuli. Congruent with our hypothe-
sis, we observed that IL-4 pretreated APs exhibited enhanced
capacity for beige adipogenesis, as assessed by the expression
of UCP1 mRNA and protein (Figures 5M and 5N). Moreover, we
observed that differentiation of APs into beige adipocytes re-
sulted in downregulation of beige adipocyte markers (Tnfrsf9,
Klhl13, and Tmem26) (Figure S6K), indicating that these markers
might work better for the identification of beige adipocyte pre-
cursors rather than the differentiated beige adipocytes in
WATs. Together, these in vitro and in vivo data suggest that
the activation of signaling via the IL-4Ra in PDGFRa+ cells is
both required and sufficient to promote the commitment of bipo-
tential APs to the beige fat lineage.
IL-4Ra Signaling in Adipocyte Precursors Controls
Growth of Beige Fat
We next asked whether loss of IL-4Ra signaling in PDGFRa+
cells alters the development of beige fat in vivo. The browning
of scWAT normally occurs when mice experience cold stress.
Since the standard vivarium temperature of 20C–22C poses
a significant thermal stress for young mice (Cannon and Ne-
dergaard, 2011; Nedergaard and Cannon, 2014), due to their
high ratio of body surface area to body mass, we asked
whether young (5-week-old) mice exhibited browning of their
scWAT. We chose this time point because it represents the
peak for scWAT AP IL-4Ra signaling and proliferation (Figures
3 and 4). Indeed, we found histological evidence for beige fatCell 160, 74–87, January 15, 2015 ª2015 Elsevier Inc. 81
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Figure 6. IL-4Ra Signaling in Adipocyte Precursors Directs Growth of Beige Fat
(A) Representative sections of scWAT from 5-week-old Il4raf/f and Il4raf/f/PdgfraCremice were stained with hematoxylin and eosin. 100x magnification (top), 400x
magnification (bottom). (B) UCP1 protein expression in scWAT and BAT of 5-week-old Il4raf/f and Il4raf/f/PdgfraCre mice housed at 22C (n = 3 per genotype).
(C–F) Assessment of metabolic rate, food intake, and activity in 5-week-old Il4raf/f and Il4raf/f/PdgfraCre mice housed at 22C (n = 8 per genotype); (C) oxygen
consumption (VO2), (D) RER, (E) total activity, and (F) food intake. Data are represented as mean ± SEM.development in the scWAT of control (Il4raf/f) mice housed at
20C–22C, which was decreased in the Il4raf/fPdgfraCre
mice (Figure 6A). Specifically, Il4raf/f mice demonstrated com-
plete replacement of multiple adjacent central scWAT lobulesFigure 5. IL-4 and IL-13 Direct Commitment of PDGFRa+ Adipocyte Pr
(A) Quantitative RT-PCR analysis of beige adipocyte precursor markers in APs p
condition and time point; data presented as mean ± SD).
(B) Quantitative RT-PCR analysis of beige adipocyte precursor markers in APs pu
48 hr (n = 3 per genotype and treatment; data presented as mean ± SD).
(C–E) Flow cytometric analysis of IL-4Ra (C), CD137 (D) and TMEM26 (E) expressi
shaded histogram: IL-4.
(F–H) Quantification of IL-4Ra, CD137, and TMEM26 expression in scWATAPs 48
of CD137 and TMEM26 expression in the scWAT APs of Il4raf/f and Il4raf/f/PdgfraC
(K and L) Quantification of CD137 and TMEM26 expression in the scWAT APs o
(M) Quantitative RT-PCR analysis of beige/brown adipocyte genes after in vitro
genotype and treatment; data presented as mean ± SD).
(N) Immunoblot analysis for UCP1 and IL-4Ra in in vitro-differentiated APs. MDI re
treatment).
Unless otherwise indicated, data are represented as mean ± SEM. See also Figuwith multiloculated beige adipocytes, while beiging in Il4raf/f
PdgfraCre mice, in contrast, involved fewer scWAT lobules,
each of which exhibited less complete beiging (i.e., retained
more cells with white adipocyte morphology). In agreementecursors to Beige Adipogenic Precursors
urified from the scWAT of C57BL/6J stimulated with vehicle or IL-4 (n = 3 per
rified from Balb/cJ or Il4ra/mice that were stimulated with vehicle or IL-4 for
on in scWAT APs of mice injected with vehicle or IL-4. Clear histogram: vehicle;
hr after administration of vehicle or IL-4 (n = 5 per treatment). (I, J) Quantification
remice 48 hr after administration of IL-4 (n = 4–6 per genotype and treatment).
f 5-week-old Il4raf/f and Il4raf/f/PdgfraCre mice (n = 8–12 per genotype).
differentiation of scWAT APs purified from Balb/cJ or Il4ra/ mice (n = 3 per
fers to stimulation of differentiation by adipogenic cocktail, (n = 3 genotype and
re S5 and S6.
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Figure 7. IL-4Ra Signaling in Mature Adipocytes Is Dispensable for Growth of Beige Fat
(A) Histological analysis of scWAT of 5-week-old Il4raf/f and Il4raf/f/AdipoqCre mice housed at 22C. Representative sections were stained with hematoxylin and
eosin, and images are shown at 1003 magnification (top) and 4003 magnification (bottom).
(B) Immunoblot analysis of UCP1 protein expression in scWAT and BAT of 5-week-old Il4raf/f and Il4raf/f/AdipoqCre mice.
(C–F) Assessment of energy expenditure in 5-week-old Il4raf/f and Il4raf/f/AdipoqCremice was performed using CLAMS; (C) oxygen consumption (VO2), (D) RER,
(E) total activity, and (F) food intake. Data are represented as mean ± SEM.with these histological data, immunoblot analysis for UCP1
protein demonstrated its robust expression in the scWAT of
Il4raf/f but not Il4raf/fPdgfraCre mice (Figure 6B). In contrast,
we did not observe significant differences among the geno-
types in expression of UCP1 protein in interscapular brown
adipose tissue (Figure 6B), which develops from distinct
myogenic precursors (Lepper and Fan, 2010; Seale et al.,
2008).
To investigate whether browning of scWAT in young mice
contributed to total body energy expenditure, we studied
5-week-old mice Il4raf/f and Il4raf/fPdgfraCre mice using the
Comprehensive Lab Animal Monitoring Systems (CLAMS).
Energy expenditure, as quantified by total oxygen consumption
(VO2) per mouse, was significantly lower (20%–25%) in
Il4raf/fPdgfraCre mice in both the day and night cycle (Figure 6C).
This reduction in VO2 was unlikely to be a consequence of
changes in total locomotor activity, RER, or food intake, which
were similar between the two genotypes (Figure 6D–6F).
Together, these results demonstrate that IL-4Ra signaling in84 Cell 160, 74–87, January 15, 2015 ª2015 Elsevier Inc.adipocyte precursor cells is a critical regulator for the develop-
ment of postnatal beige fat.
IL-4Ra Signaling in Mature Adipocytes Is Dispensable
for Growth of Beige Fat
Because adipogenic precursors give rise to mature adipo-
cytes (Berry et al., 2014), it remains plausible that the meta-
bolic phenotypes observed in Il4raf/fPdgfraCre mice result
from loss of IL-4Ra signaling in mature adipocytes. To
address this possibility, we generated mice in which the
Il4ra gene was selectively deleted in differentiated adipocytes
(designated Il4raf/fAdipoqCre). Consistent with its primary role
in APs, deletion of Il4ra in mature adipocytes did not affect
beige fat development as assessed histologically and by
immunoblotting for UCP1 (Figures 7A, 7B and S6L). Accord-
ingly, Il4raf/f and Il4raf/fAdipoqCre mice had similar rates of
oxygen consumption, RER, total activity, and food intake
(Figures 7C–7F). These findings are consistent with the ob-
servations that IL-4Ra is highly expressed in adipogenic
precursors but not in mature adipocytes (Figures 5N
and S5C).
DISCUSSION
We have previously demonstrated that exposure to environ-
mental cold induces an innate type 2 response to stimulate the
growth of beige fat. This efferent innate circuit consists of IL-4-
secreting eosinophils and catecholamine-producing alterna-
tively activated macrophages (Nguyen et al., 2011; Qiu et al.,
2014). Here we have identified two additional components of
this thermogenic circuit, which include ILC2s and PDGFRa+ adi-
pogenic precursors. Using IL-33 to pharmacologically activate
ILC2s in thermoneutral mice, we were able to place ILC2s up-
stream of APs in the beige fat thermogenic circuit. We found
that ILC2-derived IL-13 and eosinophil-derived IL-4 functionally
cooperate to activate IL-4Ra signaling, thus promoting the
expansion and commitment of scWAT APs to the beige adipo-
cyte lineage. Surprisingly, these browning effects of IL-4 and
IL-13 were not dependent on signaling via the IL-4Ra onmyeloid
cells but rather on PDGFRa+ APs themselves. In agreement with
this, both pharmacologic and physiologic expansion of beige
adipocyte precursors was reduced in Il4raf/fPdgfraCre mice.
Taken together with our previous results, these findings suggest
that type 2 immunity regulates two key events in the biogenesis
of beige fat. First, it controls the expansion and commitment of
APs to the beige fat lineage. Second, it stimulates the differenti-
ation of beige precursor cells into beige adipocytes via myeloid
cell-derived catecholamines.
Browning of WAT has principally been studied in adult rodents
after prolonged exposure to cold (Nedergaard and Cannon,
2014; Wu et al., 2013). In these experimental paradigms, the
housing of adult mice in cold environments (4C–8C for
2 days or longer) promotes the emergence of UCP1+multilocular
beige adipocytes. The underlying assumption here has been that
prolonged cold exposure creates a mismatch between the or-
ganism’s capacity for heat generation and its heat loss to the
environment, necessitating the recruitment of additional thermo-
genic tissues to maintain thermal homeostasis (Nedergaard and
Cannon, 2014; Qiu et al., 2014). Because the normal vivarium
temperature of 20C–22C imposes a significant thermal stress
on young mice, in which the ratio of body surface area to body
mass is large, we reasoned that it might be a powerful stimulus
for the recruitment of UCP1+ beige adipocytes. Indeed, we found
histological evidence for browning in the scWAT of 5-week-old
mice housed at 20C–22C. Unlike the cold-induced browning
in adult mice, which is generally patchy and incomplete even
within individual lobules, this ‘‘physiologic’’ browning of the
scWAT in young mice was more widespread, involving entire
adjacent lobules (Figures 6A and 7A). Thus, we suggest that,
as an alternative to the classic experimental paradigm of housing
adult mice at 4C–8C, investigations of the physiologic brown-
ing process in young mice might yield useful insights into the
mechanisms that regulate beige fat biogenesis.
Although the stages of scWAT development have been stud-
ied previously (Wang et al., 2013), the physiologic signals that
regulate the proliferation and/or fate of scWAT APs were un-
known. Our observations that IL-33 potently stimulates prolifer-ation of PDGFRa+ APs in an IL-4/13- and IL-4Ra-dependent
manner (Figures 2K and 2L) led us to investigate whether type
2 cytokines might be the physiologic signals controlling the
expansion of PDGFRa+ APs in the scWAT. Indeed, we found
that loss of type 2 cytokine signaling decreased the proliferation
rate and number of PDGFRa+ APs by 50% in scWAT. Interest-
ingly, this signaling pathway also regulated the commitment of
PDGFRa+ APs to the beige adipocyte precursors in a cell auton-
omous manner. Since the proliferation rate of PDGFRa+ APs de-
clines with age (Figures 3A and 3B), our results suggest that the
activation of type 2 cytokine signaling in the early postnatal
period establishes a pool of PDGFRa+ beige adipocyte precur-
sors, which are subsequently recruited by cold stress to
generate beige adipocytes in the adult organism. Perhaps, these
data also provide an explanation for the old observation that
thermogenic adaptations to cold decline with aging (Talan
et al., 1985).
Our gain- and loss-of-function studies suggest that type 2
innate immune cells have discrete roles in controlling the
numbers and fate of PDGFRa+ adipocyte precursors in the
scWAT of mice. During physiologic development of this tissue,
eosinophil-derived IL-4 seems to play a critical role in the ho-
meostatic expansion of PDGFRa+ APs into beige adipocyte pre-
cursors in young mice (Figures 3E, 3F, S6G, and S6H). However,
IL-33-induced pharmacologic expansion of scWAT APs in adult
animals seems to occur independently of eosinophils (Fig-
ure S2H). Since both ILC2s and signaling via the IL-4Ra are
required for IL-33-mediated proliferation of scWAT APs and their
subsequent differentiation into beige adipocytes (Figures 2K–
2P), it suggests that secretion of IL-13 by ILC2smight be a domi-
nant mechanism by which this tissue responds to environmental
stress. Thus, in the future, it will be critical to examine the require-
ment of and mechanisms by which ILC2s and IL-33 regulate the
development of functional beige fat during cold stress.
Finally, together with previous studies, our work provides
mechanistic insights into how mammals adapt and acclimatize
to environmental cold. During an acute cold challenge, mice
defend their core body temperature by quickly activating ther-
mogenesis. This rapid increase in heat production, which occurs
within seconds to minutes, is mediated by several thermoeffec-
tors, including cutaneous vasoconstriction, skeletal muscle
shivering, and UCP1-mediated respiration in brown adipocytes;
processes that are all activated by the sympathetic nervous sys-
tem (Cannon and Nedergaard, 2011; Lowell and Spiegelman,
2000). In contrast, prolonged cold stress induces cellular pro-
grams for acclimatization, such as the de novo recruitment of
beige adipocytes (Harms and Seale, 2013), which occur on a
longer time frame (days to weeks to months) for more stable
physiologic adaptations. Although programs of acclimatization
are well documented across species and are of great interest
to evolutionary biologists, their mechanisms, with a few excep-
tions (such as changes in skin pigmentation in response to sun-
light or increase in oxygen carrying capacity after living at high
altitudes), are largely unknown. Through our work, we have iden-
tified the mechanism for acclimatization to environmental cold.
Unlike the acute adaptations that are initiated by the sympathetic
nervous system, acclimatization to environmental cold is orches-
trated by type 2 immune cells (ILC2s, eosinophils, andCell 160, 74–87, January 15, 2015 ª2015 Elsevier Inc. 85
alternatively activated macrophages) and signals (IL-33, IL-4,
and -13), which sequentially regulate the expansion, commit-
ment, and differentiation of adipocyte precursors into beige ad-
ipocytes. Our identification of the immune system as the primary
thermogenic circuit controlling the cold acclimatization process
is consistent with a recent proposal that type 2 immunity co-
evolved as a defensive strategy against noxious environmental
stimuli (Palm et al., 2012; Profet, 1991), of which cold might be
one.
EXPERIMENTAL PROCEDURES
Animal Studies
All animal studies were conducted at UCSF under an approved IACUC proto-
col. Mice were housed at 20C–22C (unless otherwise stated) in the vivarium
under a 12 hr light:dark cycle. Both male and female mice of various ages were
used in these studies. The following animal strains were on the BALB/cJ back-
ground: WT, Il4/13/, Il4ra/, Stat6/, 4get, and 4get-DdblGATA, whereas
WT, R5 (Il5Red5/+), R5R5 (Il5Red5/Red5), R5Smart13 (Il5Red5/+Il13Smart/+), Il4ra/,
Ucp1/, Il4raf/f, Il4raf/fLyz2Cre, Il4raf/fPdgfraCre, and Il4raf/fAdipoqCre were on
the C57BL6/J background. Rag2/ and Rag2Il2rg/ were purchased from
Taconic. At the conclusion of experiments, tissues were harvested and snap
frozen in liquid nitrogen for molecular analyses, fixed in 10% formalin for his-
tology, or digested for flow cytometric analyses of adipocyte precursors and
immune cells. For gain-of-function studies, 8- to 12-week-old mice were in-
jected intraperitoneally with vehicle, IL-33 (0.5–1 mg, Biolegend), IL-13
(0.5 mg, Peprotech), or IL-4 (2 mg, Peprotech) that was complexed with anti-
IL4 mAb (10 mg, clone 11B11). Activation of signaling via the IL-4Ra was as-
sessed 1–2 hr after administration of recombinant IL-4 (2 mg). For the in vivo
studies, cohorts ofR4 mice per genotype or treatment were assembled and
experiments were repeated 2–3 independent times.
Statistical Analysis
Data were analyzed using Prism (Graphpad) and are presented as mean ±
SEM ormean ± SD. Statistical significance was determined using the unpaired
two-tailed Student’s t test for single variables and two-way ANOVA followed
by Bonferroni posttests for multiple variables. A p value of < 0.05 was consid-
ered to be statistically significant and is presented as * (p < 0.05), ** (p < 0.01),
or *** (p < 0.001).
Extended Experimental Procedures are included in the Supplemental
Information.
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